Supramolecular peptide vaccines: tuning adaptive immunity

• Successful immunotherapies must target a precise phenotype and strength of an immune response.
• Supramolecular materials may offer strategies for identifying and eliciting such phenotypes.
• Comparative studies of how material properties influence immune phenotypes are in early stages.

Successful immunotherapies must be designed to elicit targeted immune responses having a specifiable phenotype across many dimensions, including the phenotypes of T cells, B cells, antigen-presenting cells, and others. For synthetic or subunit vaccines, stimulation of strong enough immune responses usually requires adjuvants, which can cause local inflammation and complicate the targeting of such phenotypes. Supramolecular materials provide routes for reducing or eliminating supplemental adjuvants. Owing to their compositional controllability, supramolecular assemblies show promise for fine-tuning immune responses by adjusting combinations of material attributes including epitope content, multivalency, size, dose, and small quantities of specific adjuvants. Here we focus on supramolecular vaccines incorporating multiple epitopes in precise ratios, with an emphasis on peptides that form high-aspect ratio (i.e. fibrillar) structures.

Figure optionsDownload high-quality image (155 K)Download as PowerPoint slide